To: Bayer Board Of Directors

Dear Bayer: Fire. This. Clown.

"We did not develop this product for the Indian market."
- Bayer CEO Marijn Dekker on their cancer-fighting drug with a $69,000 consumer pricetag.

We are outraged about Bayer CEO Marijn Dekker's recent comments regarding people having affordable access to Bayer's new $69,000 a year cancer-fighting drug.

Bayer should fire Dekker and make its medicines affordable to all those in need.

Why is this important?

Last month, Bayer CEO Marijn Dekkers was discussing Bayer’s new cancer-fighting drug, Nexavar, at a conference hosted by the Financial Times. Nexavar costs a scandalous $69,000 for an annual supply, and India’s patent court has taken action to make the drug available for a price that India’s people can afford.

When Dekkers was asked about India’s decision his response was:

“Is this going to have a big effect on our business model? No, because we did not develop this product for the Indian market, let’s be honest. We developed this product for Western patients who can afford this product, quite honestly."

Join us in sending a message to Bayer and Marijn Dekker that their racist policies and corporate class warfare will not be tolerated: it's time to fire Marijn Dekker and make cancer-fighting medication affordable to those who need it.